image stats
date added
previous votes
log in


indent register
indent recover

mRNA BioNtech investor info - they knew how bad it is

1 star2 stars3 stars4 stars5 stars
mRNA BioNtech investor info - they knew how bad it is

Comments for: mRNA BioNtech investor info - they knew how bad it is
Onyma Report This Comment
Date: January 17, 2022 01:00AM

Hey genius, this is talking about immunotherapy treatments. Immunotherapy is NOT the same as a Vaccine, they are completely distinct from each other in methodologies and intent. Once again showing your complete lack of research and understanding.

Edited 1 time(s). Last edit at 17/01/2022 01:01AM by Onyma.
pulse Report This Comment
Date: January 17, 2022 03:23AM

Shush, it doesn't support a bullshit narrative if you try to make sense of it.
Anon Report This Comment
Date: January 17, 2022 05:43AM

Uploader here, as some people don't have basic comprehension, let me give you a hint: read the words after "immunotherapy".

Now for the really bad news:

"The biodistribution study obtained by Bridle shows the COVID spike protein gets into the blood where it circulates for several days post-vaccination and then accumulates in organs and tissues including the spleen, bone marrow, the liver, adrenal glands and in “quite high concentrations” in the ovaries.
In a study published in Nature Neuroscience, lab animals injected with purified spike protein into their bloodstream developed cardiovascular problems. The spike protein also crossed the blood-brain barrier and caused damage to the brain.
>Once in circulation, the spike protein can attach to specific ACE2 receptors that are on blood platelets and the cells that line blood vessels, Bridle said. “When that happens it can do one of two things. It can either cause platelets to clump, and that can lead to clotting — that’s exactly why we’ve been seeing clotting disorders associated with these vaccines. It can also lead to bleeding,” he added.
Whelan was concerned the mRNA vaccine technology utilized by Pfizer and Moderna had “the potential to cause microvascular injury (inflammation and small blood clots called microthrombi) to the brain, heart, liver and kidneys in ways that were not assessed in the safety trials.”


"There are many lessons to learn from the way studies are conducted and results are presented. With the use of only RRRs, and omitting ARRs, reporting bias is introduced, which affects the interpretation of vaccine efficacy.
When communicating about vaccine efficacy, especially for public health decisions such as choosing the type of vaccines to purchase and deploy, having a full picture of what the data actually show is important, and ensuring comparisons are based on the combined evidence that puts vaccine trial results in context and not just looking at one summary measure, is also important. Such decisions should be properly informed by detailed understanding of study results, requiring access to full datasets and independent scrutiny and analyses."

Plus the documentation presented to promote these vaccines deliberately ignored ARR results in favour of RRR results, making them look more impressive. In other words they used fraud. The real effectiveness:

AstraZeneca–Oxford: 1·3%
Moderna–NIH: 1.2%
Johnson & Johnson.: 1.2%
Gamaleya - Sputnik V: 0.93%
Pfizer - BioNTech: 0.84%